Back
Day Range
$3.86
$4.10
52-Week Range
$3.20
$6.99
Volume
1,200
50D / 200D Avg
$4.29
/
$4.91
Prev Close
$3.86
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 49.7 | 0.4 |
| P/B | 0.3 | 2.9 |
| ROE % | 0.5 | 3.7 |
| Net Margin % | 2.6 | 3.8 |
| Rev Growth 5Y % | -29.9 | 10.0 |
| D/E | 0.4 | 0.2 |
Key Takeaways
Revenue declined -29.86% annually over 5 years
ROE of 0.53% is below average
Debt/Equity of 0.41 — conservative balance sheet
Negative free cash flow of -626.43M
P/E of 49.66 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 55.98%
Growth
Revenue Growth (5Y)
-29.86%
Revenue (1Y)26.12%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
0.53%
ROIC0.25%
Net Margin2.61%
Op. Margin2.24%
Safety
Debt / Equity
0.41
Current Ratio2.42
Interest Coverage0.00
Valuation
P/E Ratio
49.66
P/B Ratio0.27
EV/EBITDA77.49
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.12% | Revenue Growth (3Y) | 73.61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -29.86% | Earnings Growth (5Y) | -65.49% |
| Profitability | |||
| Revenue (TTM) | 1.04B | Net Income (TTM) | 27.15M |
| ROE | 0.53% | ROA | 0.34% |
| Gross Margin | 0.00% | Operating Margin | 2.24% |
| Net Margin | 2.61% | Free Cash Flow (TTM) | -626.43M |
| ROIC | 0.25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.41 | Current Ratio | 2.42 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 49.66 | P/B Ratio | 0.27 |
| P/S Ratio | 1.30 | PEG Ratio | -2.89 |
| EV/EBITDA | 77.49 | Dividend Yield | 0.00% |
| Market Cap | 1.35B | Enterprise Value | 1.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.04B | 824.88M | 345.18M | 1.03B | 4.30B |
| Net Income | 27.15M | -378.88M | -1.48B | -909.43M | 1.91B |
| EPS (Diluted) | 0.11 | -1.53 | -6.01 | -3.69 | 7.74 |
| Gross Profit | 0.0 | 580.45M | -876.02M | -186.61M | 3.00B |
| Operating Income | 23.30M | -403.39M | -2.04B | -1.37B | 1.94B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 7.96B | 9.32B | 11.47B | 11.87B | 6.75B |
| Total Liabilities | 3.05B | 4.03B | 4.22B | 3.33B | 677.22M |
| Shareholders' Equity | 4.91B | 5.27B | 6.75B | 8.00B | 6.07B |
| Total Debt | 2.01B | 2.70B | 2.70B | 1.37B | 142.54M |
| Cash & Equivalents | 1.56B | 2.05B | 3.39B | 5.46B | 4.45B |
| Current Assets | 4.28B | 5.18B | 7.73B | 9.29B | 5.42B |
| Current Liabilities | 1.77B | 2.59B | 2.94B | 2.87B | 412.85M |